Remove stat-awards
article thumbnail

Lotte Knudsen, who pushed Novo Nordisk into the Ozempic era, wins STAT Innovation award

STAT

Back in the 1990s, scientist Lotte Bjerre Knudsen was tasked with revitalizing a floundering program at Novo Nordisk that had been trying to harness the newly-discovered GLP-1 hormone into viable diabetes drug candidates. At the time, many of Knudsen’s bosses had already lost hope for the program.

Diabetes 317
article thumbnail

STAT turns 8: A letter from the executive editor

STAT

Today STAT turns 8. Murrow awards. Today I have a more pointed appeal: for you to buy a STAT+ subscription. Or I express my pride over our staff being named Pulitzer or Emmy finalists, and our consecutive Polk and Edward R. Read the rest…

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: How a cash-prize system that phases out patents may lower drug prices

STAT

moved a step closer to an idea he has championed for some time — awarding prizes, instead of patents, for inventing medicines. government would finance more drug research and award cash prizes to companies when they invent drugs or hit milestones. Continue to STAT+ to read the full story… T wo months ago, Sen.

article thumbnail

Listen: Is the Nobel committee evolving? Plus, preventing public health’s wiliest virus

STAT

And is the oft-criticized institution that awards the Nobel Prize each year showing signs of evolution? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Will we ever get an HIV vaccine?

Vaccines 274
article thumbnail

STAT+: Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace

STAT

By doing so, a drugmaker can circumvent prohibitions on awarding more than one patent for an invention. Continue to STAT+ to read the full story… As a result, a drug company can quickly add a number of patents that can be used to protect its medicines from would-be rivals.

article thumbnail

Perfection is too high a bar for CRISPR treatments, says STAT Biomedical Innovation Award winner David Liu

STAT

But he didn’t expect her response would be both profound and incisive: “I explained to her it’s like a pair of scissors that cuts DNA, except, crucially it can be programmed,” he said Tuesday during the 2022 STAT Summit in Boston. “And she said, ‘Well, how do you fix DNA by cutting it?’”

246
246
article thumbnail

STAT+: Roivant’s CEO is a star, but even a blockbuster deal can’t escape biotech’s black hole

STAT

It’s a subjective award, but deal-making acumen, management skills, and delivering shareholder value are important measuring sticks. Continue to STAT+ to read the full story… Gline created $5 billion from $50 million — in less than one year. Regular readers know that every December, I choose a best biopharma CEO.

275
275